Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. a position paper from the heart failure association (hfa) and the working group on myocardial function of the european society of cardiology (esc)

HIGHLIGHTS

• who: POSITION PAPER and collaborators from the of Cardiology, University Medical Center Groningen, University of Groningen, Groningen, The Netherlands have published the Article: Targeted therapies in genetic dilated and hypertrophic cardiomyopathies: from molecular mechanisms to therapeutic targets. A position paper from the Heart Failure Association (HFA) and the Working Group on Myocardial Function of the European Society of Cardiology (ESC), in the Journal: (JOURNAL) of 17/Dec/2021
• future: It will be important to see to which extent financiers are willing to fund such personal medicine approaches in the cardiomyopathies in the future. Future studies . . .
  

   

  

  If you want to have access to all the content you need to log in!

  Thanks :)

  Username or E-mail:

  If you don't have an account, you can create one here.